These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9384461)

  • 1. Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method.
    Jerling M; Merlé Y; Mentré F; Mallet A
    Br J Clin Pharmacol; 1997 Nov; 44(5):447-53. PubMed ID: 9384461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence from a population pharmacokinetics analysis for a major effect of CYP1A2 activity on inter- and intraindividual variations of clozapine clearance.
    Dailly E; Urien S; Chanut E; Claudel B; Guerra N; Femandez C; Jolliet P; Bourin M
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):699-703. PubMed ID: 12188102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients.
    Doude van Troostwijk LJ; Koopmans RP; Vermeulen HD; Guchelaar HJ
    Eur J Pharm Sci; 2003 Dec; 20(4-5):451-7. PubMed ID: 14659489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
    Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
    J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement.
    van der Weide J; Steijns LS; van Weelden MJ
    Pharmacogenetics; 2003 Mar; 13(3):169-72. PubMed ID: 12618594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Population pharmacokinetics research of clozapine in Chinese schizophrenic patients].
    Qiu XW; Fu PX; Wang CY; Liu M; Zhou TY; Lu W
    Yao Xue Xue Bao; 2009 Jul; 44(7):785-92. PubMed ID: 19806921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice.
    Aitchison KJ; Jann MW; Zhao JH; Sakai T; Zaher H; Wolff K; Collier DA; Kerwin RW; Gonzalez FJ
    J Psychopharmacol; 2000; 14(4):353-9. PubMed ID: 11198052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CYP1A2 and CYP2D6 polymorphisms on drug metabolism and on insulin and lipid elevations and insulin resistance in clozapine-treated patients.
    Melkersson KI; Scordo MG; Gunes A; Dahl ML
    J Clin Psychiatry; 2007 May; 68(5):697-704. PubMed ID: 17503978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring clozapine pharmacokinetics in Tunisian schizophrenic patients: A population-based modelling approach investigating the impact of genetic and non-genetic variables.
    Mansour K; Fredj NB; Ammar H; Romdhane HB; Mhalla A; Chaabane A; Chadli Z; Aouam K
    Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):805-817. PubMed ID: 38599832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
    Jaquenoud Sirot E; Knezevic B; Morena GP; Harenberg S; Oneda B; Crettol S; Ansermot N; Baumann P; Eap CB
    J Clin Psychopharmacol; 2009 Aug; 29(4):319-26. PubMed ID: 19593168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.
    Ammar H; Chadli Z; Mhalla A; Khouadja S; Hannachi I; Alshaikheid M; Slama A; Ben Fredj N; Ben Fadhel N; Ben Romdhane H; Chaabane A; Boughattas NA; Gaha L; Zarrouk L; Aouam K
    Pharmacogenomics J; 2021 Oct; 21(5):551-558. PubMed ID: 33731885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta-analysis.
    Na Takuathung M; Hanprasertpong N; Teekachunhatean S; Koonrungsesomboon N
    Acta Psychiatr Scand; 2019 Jan; 139(1):15-25. PubMed ID: 30112761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine.
    Eiermann B; Engel G; Johansson I; Zanger UM; Bertilsson L
    Br J Clin Pharmacol; 1997 Nov; 44(5):439-46. PubMed ID: 9384460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
    Kootstra-Ros JE; Smallegoor W; van der Weide J
    Ann Clin Biochem; 2005 May; 42(Pt 3):216-9. PubMed ID: 15949157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics.
    Albitar O; Harun SN; Sheikh Ghadzi SM
    CNS Drugs; 2024 Jul; 38(7):571-581. PubMed ID: 38836990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a future for
    Ruan CJ; de Leon J
    Pharmacogenomics; 2020 Apr; 21(6):369-373. PubMed ID: 32308139
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.
    Haslemo T; Eikeseth PH; Tanum L; Molden E; Refsum H
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1049-53. PubMed ID: 17089108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic study.
    Ng W; Uchida H; Ismail Z; Mamo DC; Rajji TK; Remington G; Sproule B; Pollock BG; Mulsant BH; Bies RR
    Ther Drug Monit; 2009 Jun; 31(3):360-6. PubMed ID: 19349931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2.
    Plowchalk DR; Rowland Yeo K
    Eur J Clin Pharmacol; 2012 Jun; 68(6):951-60. PubMed ID: 22258279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring.
    Khan AY; Preskorn SH
    J Psychiatr Pract; 2005 Sep; 11(5):289-301. PubMed ID: 16184070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.